400-115-0588
在線咨詢產(chǎn)品分類
快速訂購(gòu)
31952518
- 029-86354885
- 18392009562
sales@xarxbio.com
Hot APIs cancer
| Item No | Product Name | Product Description | Product Description | Inquiry |
|---|---|---|---|---|
| R-SX-720 | IDO inhibitor 1,CAS1204669-37-3 | Epacadostat, also known as INCB024360 or INCB24360, is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities. IDO is an immunomodulatory enzyme produced by some alternatively activated macrophages and other immunoregulatory cells (also used as an immune subversion strategy by many tumors). Interferon-gamma has an antiproliferative effect on many tumor cells and inhibits intracellular pathogens such as | 查看詳細(xì) | |
| R-SX-721 | ACT-678689,CAS1783256-96-1 | ACT-678689,CAS1783256-96-1,西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-722 | Avitinib (AC0010),CAS1557267-42-1 | Avitinib (AC0010)是不可逆的EGFR抑制劑，對(duì)于突變型EGFR具有選擇性，對(duì)EGFR L858R/T790M雙突變體的IC50為0.18 nM，是對(duì)野生型EGFR效力的近43倍（IC50=7.68 nM for WT EGFR）。Avitinib具有抗**活性和耐受性毒性。西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-723 | LY2608204,CAS1234703-40-2 | LY2608204 activates glucokinase (GK) with EC50 of 42 nM. Phase 2.西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-724 | Abemaciclib; LY2835219,CAS1231929-97-7 | Abemaciclib (LY2835219) 是具有選擇性的 CDK4/6 抑制劑，能夠抑制 CDK4/CDK6 的活性，IC50 分別為 2 nM 和 10 nM。 西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-725 | 米卡芬凈Micafungin;FK463,CAS235114-32-6 | Micafungin (Mycamine; FK463) 是抗真菌化合物，能抑制真菌細(xì)胞壁中的1,3-beta-D-葡聚糖合酶,西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-726 | Eliglustat (Synonyms: Genz 99067),CAS491833-29-5 | Eliglustat是高效特異，有口服活性的葡糖腦苷脂合成酶抑制劑，IC50值為24 nM。 西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-727 | UK-2A,CAS167173-85-5 | UK-2A,CAS167173-85-5,西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-728 | AM580 (Synonyms: CD336; NSC608001; Ro 40-6055),CAS102121-60-8 | AM580是選擇性的 RARα 激動(dòng)劑，IC50 和 EC50 分別為8 nM，0.36 nM。西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-729 | Brivaracetam;UCB 34714;UCB-34714;UCB34714; Briviact,CAS357336-20-0 | Brivaracetam has been tested in a comprehensive safety pharmacology, toxicology, developmental toxicology, and genotoxicity program. It is of low acute toxicity, target organ for toxic effects is the hepatobiliary tract. Carcinogenicity studies are ongoing. Human pharmacology studies have shown that brivaracetam has a half-life of 8 h and nearly complete bioavailability . CSD episodes were regularly elicited on slices upon delivery of calibrated KCl drops and were recorded via two micropipette e | 查看詳細(xì) | |
| R-SX-730 | Anamorelin ; RC-1291,CAS249921-19-5 | Anamorelin 是一種新型 ghrelin receptor 激動(dòng)劑，F(xiàn)LIPR 檢測(cè)中，EC50 為 0.74 nM。西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
| R-SX-731 | Rolapitant;SCH619734,CAS552292-08-7 | Rolapitant (SCH619734)是高效選擇性具有口服活性的 neurokinin NK1 受體抑制劑，Ki值為0.66 nM。西安瑞禧生物提供各種抑制劑材料。 | 查看詳細(xì) | |
庫(kù)存查詢